6505--REGIMED - HYDROCORTISONE ACETATE 25MG RTL SUPP 12CT & 24CT LINE ITEM 1-12
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA) has awarded REGIMED MEDICAL a contract for Hydrocortisone Acetate 25mg Rectal Suppositories in 12ct and 24ct packaging, valued at $139,996.32. This award was made on April 10, 2026, under Solicitation Number 36C77026Q0087.
Scope of Work
This award covers the procurement of Hydrocortisone Acetate 25mg Rectal Suppositories in both 12-count and 24-count packaging. These pharmaceutical supplies are intended for the VA's Consolidated Mail Outpatient Pharmacies (CMOPs).
Contract Details
- Awardee: REGIMED MEDICAL
- Award Number: 36C77026P0083
- Award Amount: $139,996.32
- Award Date: April 10, 2026
- Set-Aside: Total Small Business Set-Aside (SBA)
- Contracting Office: NATIONAL CMOP OFFICE (36C770)
- Product Service Code (PSC): 6505 (Drugs And Biologicals)
- NAICS Code: 325412 (Pharmaceutical Preparation)
Evaluation
The original solicitation (36C77026Q0087) for this requirement considered factors such as Delivery, Past Performance, Price, and Technical capability, with the Government reserving the right to award based on the most advantageous offer.
Additional Notes
The award specifically covered Line Item Number 12 of the solicitation. The original solicitation required products to be shippable by USPS, include bar code labeling (GS1-128 or HIBCC), be FDA "A" rated (unless family group is "B"), have expiration dates no less than 12 months from delivery, and comply with the Drug Supply Chain Security Act (DSCSA).